IHC antibody for Colon Cancer

Immunohistochemical techniques is a methodology which based on antigen-antibody immunological response to its theoretical foundation. It plays an important role in basic and clinical medical research in the field of biology, especially in the diagnosis of diseases of the tumors, differential diagnosis and pathogenesis research provides a powerful tool. With the development of new technologies, hundreds of kinds of antibodies used in various areas of clinical research, the majority of these antibodies play an important supporting role in the diagnosis of difficult cases. It has important implications for the patient's prognosis and guide treatment.

Colon cancer is the most common cancer in recent years, there are many possible markers be used in the diagnosis of colon cancer, these markers can be detected in serum, tissue and feces and thus given some guidance in the early diagnosis and prognosis of colon cancer, common tumor markers for diagnosis of colon cancer are CEA, CAl9.9, CA242, etc.

Slices of colon cancer as follows:

DMBT1: 11678-RP02

Immunochemical staining of human DMBT1 in human colon carcinoma with rabbit polyclonal antibody (1 µg/mL, formalin-fixed paraffin embedded sections).
E-cadherin: 10204-RP02

Immunochemical staining of human E-cadherin in human colon carcinoma with Rabbit Polyclonal Antibody (1 µg/mL, formalin-fixed paraffin embedded sections). Positive staining was localized to membrane of epithelial cells.
IFITM1: 100417-T44

Immunochemical staining of human IFITM1 in human colon carcinoma with rabbit polyclonal antibody (0.2 µg/mL, formalin-fixed paraffin embedded sections).